Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
SINO BIOPHARM Drops ~5% Post-results; Nomura: Interim Results Largely In Line
Recommend 15 Positive 33 Negative 5 |
||||
|
||||
|
SINO BIOPHARM (01177.HK) last traded at HKD7.53, down 4.8%, with a trading volume of 78.22 million shares, involving HKD605 million. The group announced its results after the market closed yesterday (18th). The company's turnover soared by 10.7% YoY to RMB17.575 billion, while its net profit was RMB3.389 billion, up 12.3% YoY, with EPS standing at RMB18.82 cents. Nomura wrote in its research report that SINO BIOPHARM's 1H25 results were largely in line with expectations. Considering an increase in its GPM and clearer long-term growth prospects, the broker raised its target price from HKD7.69 to HKD9.17. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
